Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial
<p>Cerebral hypoxia may promote cerebral damage in patients with obstructive sleep apnoea (OSA). We investigated whether OSA patients experience nocturnal cerebral hypoxia that is prevented by continuous positive airway pressure (CPAP).</p> <p>OSA patients using CPAP underwent slee...
Asıl Yazarlar: | Schwarz, E, Furian, M, Schlatzer, C, Stradling, J, Kohler, M, Bloch, K |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
European Respiratory Society
2018
|
Benzer Materyaller
-
ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial.
Yazar:: Schlatzer, C, ve diğerleri
Baskı/Yayın Bilgisi: (2016) -
Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta-analysis.
Yazar:: Schwarz, E, ve diğerleri
Baskı/Yayın Bilgisi: (2015) -
Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta-analysis
Yazar:: Schwarz, E, ve diğerleri
Baskı/Yayın Bilgisi: (2015) -
Pharmacological approaches to the treatment of obstructive sleep apnoea.
Yazar:: Kohler, M, ve diğerleri
Baskı/Yayın Bilgisi: (2009) -
The role of the nose in the pathogenesis of obstructive sleep apnoea and snoring.
Yazar:: Kohler, M, ve diğerleri
Baskı/Yayın Bilgisi: (2007)